SEHK:1509

Stock Analysis Report

Harmonicare Medical Holdings

Executive Summary

Harmonicare Medical Holdings Limited, an investment holding company, operates obstetrics and gynecology hospitals that provide inpatient and outpatient healthcare services.

Snowflake

Fundamentals

Reasonable growth potential with mediocre balance sheet.

Risks

  • Harmonicare Medical Holdings is covered by less than 3 analysts.

Share Price & News

How has Harmonicare Medical Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

n/a

SEHK:1509

0.5%

HK Healthcare

2.5%

HK Market


1 Year Return

-9.3%

SEHK:1509

-27.6%

HK Healthcare

-3.9%

HK Market

1509 outperformed the Healthcare industry which returned -18.7% over the past year.

1509 underperformed the Market in Hong Kong which returned -8% over the past year.


Share holder returns

1509IndustryMarket
7 Dayn/a0.5%2.5%
30 Dayn/a6.0%7.6%
90 Dayn/a-4.1%0.8%
1 Year-9.3%-9.3%-26.1%-27.6%-0.4%-3.9%
3 Year-52.3%-53.0%-29.6%-33.9%19.6%7.6%
5 Yearn/a-25.0%-31.5%17.7%-1.7%

Price Volatility Vs. Market

How volatile is Harmonicare Medical Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Harmonicare Medical Holdings undervalued based on future cash flows and its price relative to the stock market?

1.2x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Harmonicare Medical Holdings to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Harmonicare Medical Holdings to establish if it is available at substantial discount.


Price Based on Earnings

Harmonicare Medical Holdings is loss making, we can't compare its value to the HK Healthcare industry average.

Harmonicare Medical Holdings is loss making, we can't compare the value of its earnings to the Hong Kong market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Harmonicare Medical Holdings, we can't assess if its growth is good value.


Price Based on Value of Assets

Harmonicare Medical Holdings is good value based on assets compared to the HK Healthcare industry average.


Next Steps

Future Growth

How is Harmonicare Medical Holdings expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

44.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Harmonicare Medical Holdings's revenue is expected to grow by 12.3% yearly, however this is not considered high growth (20% yearly).

Harmonicare Medical Holdings's earnings are expected to grow significantly at over 20% yearly.

Harmonicare Medical Holdings's revenue growth is expected to exceed the Hong Kong market average.

Harmonicare Medical Holdings's earnings growth is expected to exceed the Hong Kong market average.

Harmonicare Medical Holdings's earnings growth is expected to exceed the low risk savings rate of 2%.


Earnings per Share Growth Estimates


Future Return on Equity

Harmonicare Medical Holdings is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Harmonicare Medical Holdings performed over the past 5 years?

-49.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Harmonicare Medical Holdings does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Harmonicare Medical Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Harmonicare Medical Holdings's 1-year growth to the HK Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Harmonicare Medical Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Harmonicare Medical Holdings has efficiently used its assets last year compared to the HK Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Harmonicare Medical Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Harmonicare Medical Holdings's financial position?


Financial Position Analysis

Harmonicare Medical Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Harmonicare Medical Holdings's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Harmonicare Medical Holdings's level of debt (6.5%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has increased over the past 5 years (0% vs 6.5% today).

Operating cash flow is negative therefore debt is not well covered.

Unable to confirm if the interest payments on Harmonicare Medical Holdings's debt are well covered by earnings due to lack of past financial data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 4.3x debt.


Next Steps

Dividend

What is Harmonicare Medical Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Harmonicare Medical Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Harmonicare Medical Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Harmonicare Medical Holdings has not reported any payouts.

Unable to verify if Harmonicare Medical Holdings's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Harmonicare Medical Holdings has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Harmonicare Medical Holdings's dividends in 3 years as they are not expected to pay a notable one for Hong Kong.


Next Steps

Management

What is the CEO of Harmonicare Medical Holdings's salary, the management and board of directors tenure and is there insider trading?

2.0yrs

Average management tenure


CEO

Yuming Lin (49yo)

5yrs

Tenure

CN¥519,000

Compensation

Mr. Yuming Lin is the Founder of Bosheng Medical Investment Co., Inc. and has been its Chairman and President since December 2007. Mr. Lin is the Founder, Chairman, CEO and President of Harmonicare Medical ...


CEO Compensation Analysis

Yuming's remuneration is lower than average for companies of similar size in Hong Kong.

Yuming's compensation has increased whilst company is loss making.


Management Age and Tenure

2.0yrs

Average Tenure

47yo

Average Age

The tenure for the Harmonicare Medical Holdings management team is about average.


Board Age and Tenure

4.4yrs

Average Tenure

48.5yo

Average Age

The tenure for the Harmonicare Medical Holdings board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Aries Cheung (54yo)

    Joint Company Secretary

    • Tenure: 1.3yrs
  • Yuming Lin (49yo)

    Chairman

    • Tenure: 5yrs
    • Compensation: CN¥519.00k
  • Zhifeng Fang (45yo)

    VP & Executive Director

    • Tenure: 4.4yrs
  • Wei Chen (40yo)

    VP & Joint Company Secretary

    • Tenure: 0yrs
  • Wenfeng Li (64yo)

    Vice-President of Sourcing and Audit Management

    • Tenure: 2yrs
  • Jinhui Ren (43yo)

    VP & CFO

    • Tenure: 0yrs

Board Members

  • Jun Xu (51yo)

    Non-Executive Director

    • Tenure: 2.7yrs
  • Yuming Lin (49yo)

    Chairman

    • Tenure: 5yrs
    • Compensation: CN¥519.00k
  • Zhifeng Fang (45yo)

    VP & Executive Director

    • Tenure: 4.4yrs
  • Yuguo Lin (46yo)

    Non-Executive Director

    • Tenure: 4.4yrs
  • Aiguo Kong (52yo)

    Independent Non-Executive Director

    • Tenure: 4.4yrs
    • Compensation: CN¥200.00k
  • Lan Fang (48yo)

    Independent Non-Executive Director

    • Tenure: 4.4yrs
    • Compensation: CN¥200.00k
  • Jiang Nan Cai (62yo)

    Independent Non-Executive Director

    • Tenure: 4.4yrs
    • Compensation: CN¥200.00k
  • Jianwei Qiu (43yo)

    Non-Executive Director

    • Tenure: 2.7yrs

Company Information

Harmonicare Medical Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Harmonicare Medical Holdings Limited
  • Ticker: 1509
  • Exchange: SEHK
  • Founded: 2002
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: HK$1.517b
  • Shares outstanding: 743.48m
  • Website: https://www.hemeiyl.com

Number of Employees


Location

  • Harmonicare Medical Holdings Limited
  • No. A2 Xiaoguan Beili
  • Beiyuan Road
  • Beijing
  • 100029
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
1509SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDJul 2015
157DB (Deutsche Boerse AG)YesOrdinary SharesDEEURJul 2015

Biography

Harmonicare Medical Holdings Limited, an investment holding company, operates obstetrics and gynecology hospitals that provide inpatient and outpatient healthcare services. The company operates through Spe ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/01 13:00
End of Day Share Price2019/07/30 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.